Advertisement
Advertisement
Wuxi AppTec
TOPIC
 / company

Wuxi AppTec

Wuxi AppTec
Wuxi AppTec
Wuxi AppTec is Asia's largest provider of contract pharmaceutical research, helping drug makers shorten their discovery and development procedures. Its platform is used by more than 6,000 customers, including biotech and pharmaceutical companies, research institutions, researchers, scientists and entrepreneurs in more than 30 countries. The company was founded by Ge Li, who also chairs Wuxi Biologics.
Chairman / President
Li Ge
CEO / Managing Director
Chen Minzhang
CFO / Finance Director
Shi Ming
Industry
Biopharmaceutical
Website
wuxiapptec.com
Headquarters address
288 Fute Zhong Road Waigaoqiao Free Trade Zone, Pudong New Area, Shanghai, China
Stock Code
SEHK:603259
SSE:603259
Year founded
2000
LATEST China Science NEWS

How a Xinjiang weed could cut China’s reliance on Southeast Asian rubber

videocam
The plant in question can be found at the foot of the Tianshan Mountains in China’s Xinjiang Uygur autonomous region. Photo: Getty Images

China is working towards 100% renewable power at its Antarctic bases by 2035

videocam
Qinling Station, China’s newest base in Antarctica, is mainly powered by clean energy. Photo: Xinhua

Is China’s climate returning to golden age of Tang dynasty? Experts warn of trap

videocam
Local media in China's northwestern Ningxia Hui autonomous region are celebrating an unusual rainfall surge in the hope of "climate dividends". Photo: Handout

Chinese rocket scientists find ‘most effective’ way to nuke a doomsday asteroid

videocam
24
Chinese engineers are developing a two-pronged method to destroy an asteroid on a collision course with Earth using a powerful nuclear bomb. Photo: Getty Images

Chinese police AI algorithm tracks bitcoin money laundering with 90% accuracy

videocam
4
Chinese police academy researchers have developed a model that can detect illegal crypto transactions with almost 90 per cent accuracy, according to a new study. Photo: AFP
MORE China Science NEWS
Wuxi AppTec, Asia’s largest provider of contract pharmaceutical research, surpassed analysts’ expectations in the first half of the year. Photo: Handout
Banking & finance

China biotech giant Wuxi AppTec sees first-half earnings surge amid US scrutiny

Strong orders for weight-loss and diabetes treatments drive firm’s growth, despite being caught up in US efforts to curb China’s ambitions.

US-China trade war

Record Chinese biotech out-licensing meets rising US scrutiny

videocam
22
Banking & finance

As weight-loss drug orders surge, global funds pile into China’s WuXi AppTec

China manufacturing

The next rare earths? Why US fears another Chinese manufacturing advantage

China’s production of drug inputs has boomed in recent years, increasing market share and prompting fears of weaponisation in Washington.

videocam
26
Illustration: Victor Sanjinez
US-China relations

Senate bill seeks to curb US reliance on China in drug industry

Lawmakers want more transparency around foreign influence in the sector, saying there’s no reason to allow rival to control supply chain.

Hong Kong stock market

Hong Kong stocks rebound from choppy trading triggered by turmoil in US

Hang Seng Index bounces back after overnight plunge in Nasdaq-100 on concerns about frothy tech valuations.

5
Advertisement
Advertisement
Advertisement
US-China relations

Pentagon sued by Alibaba over ‘arbitrary’ military blacklist targeting Chinese firms

Technology giant says US defence department wrongly labelled it a Chinese military company without evidence.

videocam
12
Alibaba has argued that its business operations are commercial in nature and unconnected to China’s military. Photo: Kyodo
China’s private sector

Bigger, fewer, tougher: the new era of China-US biotech partnerships

China’s biotech boom continues to attract Western drug makers even as Washington expands investment and technology controls.

US-China relations

China accuses US of power abuse with expanded blacklist of Chinese firms

Washington is using national security as a cover for its efforts to contain Chinese companies doing business overseas, Beijing says.

videocam
12
US-China relations

Biotech firm WuXi sues US over allegations it supports China’s military

The company says it suffered substantial reputational and operational harm after being placed on a Pentagon blacklist.

videocam
The lawsuit seeks WuXi’s removal from the Pentagon blacklist. Photo illustration: Reuters
China’s private sector

China biotech firms say global push is ‘irreversible’ despite US barriers

Chinese drug makers are increasingly relying on overseas licensing deals to reach global markets amid growing geopolitical tensions.

Chinese companies now account for about half of all global biotechnology business development deals. Photo: Shutterstock
US-China relations

How will the Pentagon’s expanded blacklist of Chinese firms affect Xi’s US visit?

Washington’s latest move tests fragile ‘stability’ reached at leadership summit in Beijing and highlights intense competition, analysts say.

videocam
27
China’s private sector

Chinese pharmaceutical firms’ cost advantages trump Pentagon blacklist: analysts

Growing collaboration between multinational drug makers and Chinese companies not expected to slow after US move.

US-China tech war

Pentagon blacklist raises spectre of investment curbs for Chinese tech firms

Chinese tech giants including Alibaba and Baidu strongly reject the Pentagon’s characterisation of them as “Chinese military companies”.

8
Chinese tech companies fear the Pentagon's blacklist will increase reputational risks and raise the possibility of further tougher sanctions. Photo: AP
US-China relations

Pentagon blacklists China tech giants as US competition expands

Alibaba, Baidu, BYD and Unitree were among Chinese companies added to a US military blacklist as competition between the nations expands further into technology.

Photo: Xinhua
Hong Kong stock market

Alibaba and WuXi AppTec decline in Hong Kong after addition to US blacklist

Designation of Chinese firms fuels investor unease, with markets bracing for a potential Fed tightening and an unwinding of the AI trade.

US-China relations

US adds Alibaba, BYD, other Chinese tech champions to military company blacklist

Trump administration has designated top China firms as ‘Chinese military companies’ operating in the United States.

videocam
64
Advertisement
Advertisement
Advertisement
Banking & finance

China sees revival of foreign investors through IPOs, convertibles: UBS

The trend is part of a broader recovery of interest in Chinese assets from investors overseas.

videocam
A terrace in Beijing’s central business district in China. Photo: Getty Images
Hong Kong company reporting season

WuXi AppTec shares surge 14% in Hong Kong after record first-quarter earnings

The Chinese company’s revenue rose nearly 29 per cent to 12.44 billion yuan, while profit surged about 27 per cent to 4.65 billion yuan.

China’s private sector

WuXi AppTec posts record first-quarter revenue on strong global demand

Earnings top estimates as multinational pharmaceutical firms ramp up investment and partnerships in China.

China’s private sector

US reshoring drive casts shadow over China’s contract drug makers, analyst says

Strong order backlogs underpin earnings through 2027, but analysts warn longer-term demand is less certain as US firms reshore production.

Despite the headwinds, there is growing interest from multinational pharmaceutical companies in partnering with Chinese biotech firms. Photo: Getty Images
China’s private sector

Lab monkey price tag climbs to US$20,000 thanks to China’s biotech boom

The cost of a single monkey exceeds the average annual salary in China and approaches a pandemic-era spike amid growth in drug licensing deals.

Founder Securities expects the annual domestic supply of experimental monkeys in China to range between 49,000 and 52,400 animals from 2025 to 2027. Photo: Shutterstock
US-China relations

Pentagon adds Chinese firms to military list, then withdraws filing

Move weeks before Trump-Xi summit highlights mixed signals from Washington and injects fresh uncertainty into fragile US-China truce.

videocam
4
Hong Kong stock market

Hong Kong stocks climb as yuan strengthens and investors broaden focus beyond US

Hang Seng Index advances as investors shift focus, boosting Asian equities, with pharmaceutical and healthcare shares leading gainers.

United States

Are Chinese biotechs what the doctor ordered as Big Pharma faces ‘patent cliff’?

US drug makers are racing to plug looming ‘patent cliff’ revenue gaps – and increasingly they are turning to China biotechs.

US drugmakers are increasingly looking to Chinese biotechs as an answer to the revenue gaps left by the looming ‘patent cliff’. Illustration by Henry Wong
US-China relations

US lawmakers want DeepSeek, Xiaomi added to list of China military-linked firms

Republicans want to add 19 more entities to the document that already includes tech giant Tencent Holdings and major ‍battery maker CATL.

videocam
17
A letter, from US lawmakers asks for AI firm DeepSeek and other Chinese companies to be put on what is known as the Section 1260H list. Photo: Reuters
Science

Why US lawmakers killed a proposal targeting science efforts with China

US researchers and industry experts warn that even the revised version may have unintended consequences.

videocam
11
Hong Kong stock market

Hong Kong stocks end higher as China stimulus hopes spark property rally

Market sentiment buoyed by China homebuyer loan support talk and Vanke debt progress.

Advertisement
Advertisement
Advertisement
Help preserve 120 years of quality journalism.
SUPPORT NOW
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement